U.S. flag

An official website of the United States government

NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly) AND Neoplasm of the large intestine

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 31, 2016
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000438613.2

Allele description [Variation Report for NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly)]

NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly)

Gene:
PIK3CA:phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q26.32
Genomic location:
Preferred name:
NM_006218.4(PIK3CA):c.1634A>G (p.Glu545Gly)
HGVS:
  • NC_000003.12:g.179218304A>G
  • NG_012113.2:g.74782A>G
  • NM_006218.4:c.1634A>GMANE SELECT
  • NP_006209.2:p.Glu545Gly
  • LRG_310t1:c.1634A>G
  • LRG_310:g.74782A>G
  • LRG_310p1:p.Glu545Gly
  • NC_000003.11:g.178936092A>G
  • P42336:p.Glu545Gly
Protein change:
E545G; GLU545GLY
Links:
UniProtKB: P42336#VAR_026177; OMIM: 171834.0004; dbSNP: rs121913274
NCBI 1000 Genomes Browser:
rs121913274
Molecular consequence:
  • NM_006218.4:c.1634A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Neoplasm of the large intestine
Synonyms:
Colorectal Neoplasms; Colorectal neoplasm
Identifiers:
MONDO: MONDO:0005335; MeSH: D015179; MedGen: C0009404; Human Phenotype Ontology: HP:0100834

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000504013Database of Curated Mutations (DoCM)
no assertion criteria provided
Pathogenic
(May 31, 2016)
somaticliterature only

PubMed (12)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedsomaticyesnot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.

Kang S, Bader AG, Vogt PK.

Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):802-7. Epub 2005 Jan 12.

PubMed [citation]
PMID:
15647370
PMCID:
PMC545580

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

De Roock W, Claes B, Bernasconi D, De Schutter J, Biesmans B, Fountzilas G, Kalogeras KT, Kotoula V, Papamichael D, Laurent-Puig P, Penault-Llorca F, Rougier P, Vincenzi B, Santini D, Tonini G, Cappuzzo F, Frattini M, Molinari F, Saletti P, De Dosso S, Martini M, Bardelli A, et al.

Lancet Oncol. 2010 Aug;11(8):753-62. doi: 10.1016/S1470-2045(10)70130-3. Epub 2010 Jul 8.

PubMed [citation]
PMID:
20619739
See all PubMed Citations (12)

Details of each submission

From Database of Curated Mutations (DoCM), SCV000504013.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (12)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 15, 2024